DALLAS, May 7, 2015 /PRNewswire/ --

According to a new market research report "Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease), & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019", published by MarketsandMarkets, the global Genome Editing Market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%.

Browse 83 market data Tables and 91 Figures spread through 170 Pages and in-depth TOC on "Genome Editing Market"

http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html
Early buyers will receive 10% customization on this report.

Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014-2019). Moreover, increasing demand for synthetic genes, and global rise in production of genetically modified crops are also expected to drive market growth. However, stringent regulatory policies and adverse public perception related to genetic research may hinder the growth of this market.

The global Genome Editing Market is segmented on the basis of applications, technologies and end users. On the basis of applications, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. Of these, the cell line engineering segment accounted for the largest share of the global Genome Editing Market in 2014. On the other hand, the animal genetic engineering segment is expected to grow at the highest growth rate during the forecast period.

Inquiry before Buying:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=231037000

By technology, the market is divided into CRISPR, TALEN, ZNF, antisense technology, and other technologies. Of these, CRISPR will account for the largest and the fastest-growing segment of the global Genome Editing Market by 2019. On the basis of end users, the Genome Editing Market is categorized into biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America includes Canada and the U.S.; and Asia includes China, India, Japan, and the Rest of Asia.

Major players of the Genome EditingMarket are GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).

Browse Related Reports: 

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User - Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation) & by End Users - Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain@  http://www.marketsandmarkets.com/Subscription.html

Contact:

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets